Company news

Insulet Corporation news in 2023

Insulet Corporation's news releases, calls and decks from 2023, newest first.

View company

Insulet Reports Third Quarter 2023 Revenue Increase of 27% Year-Over-Year (25% Constant Currency¹)

November 1, 2023

Insulet Spotlights Diabetes Awareness on World Diabetes Day and Throughout November

October 31, 2023

Insulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhone

October 22, 2023

Insulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod® 5

October 1, 2023

Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023

September 27, 2023

Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany

August 27, 2023

Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency¹)

August 7, 2023

Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023

July 4, 2023

Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions

June 21, 2023

Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom

June 19, 2023

Imperative Care Appoints Shacey Petrovic to Board of Directors

June 5, 2023

Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency¹)

May 3, 2023

Insulet Announces New Organizational Structure to Drive Further Growth

May 3, 2023

Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment

May 1, 2023

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

April 24, 2023

Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023

March 29, 2023

CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency¹) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)

February 22, 2023

Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

February 20, 2023

Insulet Acquires Assets of Automated Glucose Control LLC (AGC)

February 13, 2023

Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies

February 12, 2023

Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

January 11, 2023

Calls in 2023

Decks in 2023